奥马佐单抗
慢性荨麻疹
医学
皮肤病科
免疫学
免疫球蛋白E
抗体
作者
Michelle Meertens,Teddy Luijf,Esmee A.M. van Lindonk,Reineke Soegiharto,Salma Assil,Mehran Alizadeh Aghdam,Petra A. Kentie,André C. Knulst,Martijn B. A. van Doorn,Heike Röckmann
标识
DOI：10.1016/j.jaip.2023.07.030
摘要
We found that omalizumab can be discontinued to reveal disease remission and avoid drug exposure in patients with chronic urticaria.Higher age and fast initial response predict the need for retreatment and can be used to counsel patients in clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
dde
无极微光
AllRightReserved
嘻嘻哈哈
Nexus
Moonpie
糊涂的雅琴
Twonej
ww2026
OK
arniu2008
HFH
GingerF
Scorpia112
殷勤的紫槐
乐空思
仰望喀纳斯的星空
安详乌龟
lizishu
皖公网安备34019202002308
